Report overview
The global Pharmaceutical CDMO Solution market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Active Pharmaceutical Ingredient (API) Manufacturing Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Pharmaceutical CDMO Solution include Recipharm AB, Lonza Group, Catalent, Patheon (Thermo Fisher Scientific), Siegfried AG, SGS Quay Pharmaceuticals, Curia, Societal CDMO and Aenova Group, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical CDMO Solution, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical CDMO Solution. This report contains market size and forecasts of Pharmaceutical CDMO Solution in global, including the following market information:
Global Pharmaceutical CDMO Solution Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pharmaceutical CDMO Solution companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pharmaceutical CDMO Solution Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Pharmaceutical CDMO Solution Market Segment Percentages, by Type, 2023 (%)
Active Pharmaceutical Ingredient (API) Manufacturing
Finished Dosage Formulation (FDF) Development and Manufacturing
Secondary Packaging
Others
Global Pharmaceutical CDMO Solution Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Pharmaceutical CDMO Solution Market Segment Percentages, by Application, 2023 (%)
Innovative Medicine
Patented Drug
Patent Expired Drug
Others
Global Pharmaceutical CDMO Solution Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Pharmaceutical CDMO Solution Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pharmaceutical CDMO Solution revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Pharmaceutical CDMO Solution revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Recipharm AB
Lonza Group
Catalent
Patheon (Thermo Fisher Scientific)
Siegfried AG
SGS Quay Pharmaceuticals
Curia
Societal CDMO
Aenova Group
Eurofins CDMO
Piramal Group
WuXi AppTec Group
Fareva
Strides Pharma Science
Famar Health Care Service
Outline of Major Chapters:
Chapter 1: Introduces the definition of Pharmaceutical CDMO Solution, market overview.
Chapter 2: Global Pharmaceutical CDMO Solution market size in revenue.
Chapter 3: Detailed analysis of Pharmaceutical CDMO Solution company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pharmaceutical CDMO Solution in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
